340B Health

Who We Are

340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.

Learn more about us

340B Advocacy Matters

Your lawmakers need to hear from you! Tell them what 340B means to your community

Learn more here

340B Informed

Senate Report Blasts Insulin Makers for High Prices

January 21, 2021– A new, bipartisan report from a key congressional committee is sharply critical of the three major drug manufacturers that sell insulin in the U.S. The companies – Eli Lilly, Novo Nordisk, and Sanofi – already have been all over the news recently for their pricing

Read More

340B Employed

The Exchange